For instance, transgenic inhibition of NF-κB in glial fibrillary acidic protein (GFAP) expressing glial cells attenuated pain and neuronal inflammation after peripheral nerve injury [60]. The gene discussed is GFAP; the disease is peripheral nerve injury.